In vitro studies demonstrated PD-1 blockade partially reversed CD8 dysfunction (15), but no significant differences in cytokine secretion or polyfunctionality were observed in CD8 cells of patients with AML post-IO. Here, CD8A is linked to acute myeloid leukemia.